April 13, 2026 - April 16, 2026
Drug Discovery Chemistry is an esteemed and dynamic conference within the scientific community, acclaimed for its pivotal role in advancing medicinal, biophysical, and computational chemistry. This event is highly regarded for fostering innovation in drug discovery and optimization, offering invaluable insights and networking opportunities for professionals in the pharmaceutical, biotech, and academic sectors.
Main topics or themes covered:
- Fragment-Based Drug Discovery
- Small Molecule Strategies
- Targeted Protein Degradation
- Synthesis with Radicals
- Beyond the Rule of 5 in Drug Design
Target audience:
This conference is tailored for medicinal chemists, biophysical chemists, computational chemists, and other scientific professionals from pharma, biotech, and academia who are engaged in the discovery and development of drug candidates.
Event highlights:
– Participation from leading pharma companies like AbbVie, Amgen, and AstraZeneca
– Keynote speakers including Christopher J. Helal, PhD, and Phil Baran, PhD
– Premier and corporate sponsorships from top industry players
– Opportunities for personalized learning through concurrent tracks
– On-demand access to session recordings
Join the forefront of drug discovery innovation at Drug Discovery Chemistry, where the latest scientific advancements and strategic collaborations are unveiled, paving the way for future breakthroughs.
Keywords: drug discovery, medicinal chemistry, biotech, pharma, scientific conference
